Clonal replacement of tumor-specific T cells following PD-1 blockade
2019 · Nature Medicine · 1,488 citations
https://doi.org/10.1038/s41591-019-0522-3
K
Kavita Y. Sarin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
279
Papers
7.0K
Citations
39
h-index
91
i10-index
Kavita Y. Sarin is an academic researcher. The author has contributed to research in topics: Nonmelanoma Skin Cancer Studies & Hedgehog Signaling Pathway Studies & Cutaneous Melanoma Detection and Management. The author has an h-index of 39, co-authored 238 publications.
ORCID: 0000-0001-5363-3053Papers by this author
worksSmoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
2015 · Cancer Cell · 415 citations
https://doi.org/10.1016/j.ccell.2015.02.002
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
2015 · Cancer Cell · 384 citations
https://doi.org/10.1016/j.ccell.2015.02.001
An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
2015 · Clinical Cancer Research · 150 citations
https://doi.org/10.1158/1078-0432.ccr-15-1588
Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma
2016 · Nature Communications · 138 citations
https://doi.org/10.1038/ncomms12048
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
2018 · Journal of the American Academy of Dermatology · 115 citations
https://doi.org/10.1016/j.jaad.2018.08.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat